Half-year report · Q2
4572.TEDINET S100WEUS
Period2025-01-01 → 2025-06-30
Filed2025-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥636m | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥316m | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥2.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥3.7bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥244m | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥297m | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥222m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥567m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥279m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-121.64 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.25 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.1bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥24m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 418
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | Prior1YTDDuration | -1094118000 | JPY |
| Profit loss | CurrentYTDDuration | -1056054000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -425000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -2737000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 27374000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | － | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 40699000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -27431000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 67649000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -30169000 | JPY |
| Comprehensive income | Prior1YTDDuration | -1026469000 | JPY |
| Comprehensive income | CurrentYTDDuration | -1086224000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -1026469000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -1086224000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | -1091384000 | JPY |
| Income before income taxes | CurrentYTDDuration | -1055340000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 15477000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | － | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 4228000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 315000 | JPY |
| Interest income ope cf | Prior1YTDDuration | -2543000 | JPY |
| Interest income ope cf | CurrentYTDDuration | -2999000 | JPY |
| Dividends income ope cf | Prior1YTDDuration | -219000 | JPY |
| Dividends income ope cf | CurrentYTDDuration | -1528000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 1726000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 895000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 16908000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 11150000 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | 23109000 | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | 91000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -11257000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | 1029000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 692991000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 11624000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -7335000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -9446000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -1200000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -1694000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | 63192000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -21825000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YTDDuration | 70312000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYTDDuration | 37391000 | JPY |
| Other net ope cf | Prior1YTDDuration | 11369000 | JPY |
| Other net ope cf | CurrentYTDDuration | 34825000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -214624000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -995509000 | JPY |
| Interest income received ope cf | Prior1YTDDuration | 2543000 | JPY |
| Interest income received ope cf | CurrentYTDDuration | 4098000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |